Showing results (2121-2130 of 2,154) with videos related to

Sort By:
Pageof 216
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
European Urology Oncology|December 7, 2023
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate CancerJames P Buteau, Daniel Moon, Michael T Fahey, et al.
European Urology|September 13, 2025
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi AnalysisKen Herrmann, Jochen Walz, Steven MacLennan, et al.
Nature Microbiology|April 26, 2022
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environmentJohanna Rhodes, Alireza Abdolrasouli, Katie Dunne, et al.
JAMA Oncology|September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy TrialAndrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
The Journal of Urology|May 11, 2019
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic ApproachesPaolo Gontero, Giancarlo Marra, Paolo Alessio, et al.
The Lancet. Oncology|July 5, 2025
First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 studyJames P Buteau, Louise Kostos, Price A Jackson, et al.
Nature Communications|November 24, 2011
P-Rex1 is required for efficient melanoblast migration and melanoma metastasisColin R Lindsay, Samuel Lawn, Andrew D Campbell, et al.
Cell|March 20, 2025
Growth of the maternal intestine during reproductionTomotsune Ameku, Anna Laddach, Hannah Beckwith, et al.
The Lancet. Oncology|June 10, 2026
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trialJames P Buteau, Daniel Moon, Michael T Fahey, et al.
Pageof 216